Company Profile
United Therapeutics Corp. is a biotechnology company, which is focused on the development and commercialization of unique products to address the medical needs of patients with chronic and life threatening conditions. Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycobiological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
52 Week
Range
$69.17 / $42.52
50 / 200 Moving Average
$63.27 / $56.42YTD Change
29.48%3 Month Change
21.99%52 Week Change
64.34%Number of Employees
623Coverage Start Date
09/25/2003Number of Rating Changes
13Exchange
NASD
1040 Spring Street
Silver Spring,
MD
20910
(Map)
www.unither.com
Listed: NASD
Roger Jeffs, PhD
Martine A. Rothblatt PhD, MBA
Roger Jeffs, PhD
61.5 Market Cap: 30,058.00M
16.1 Market Cap: 0.93M
- Community
